Global Cochlear Implants Market Research Report - Forecast to 2023

Notably, rising geriatric population is the key factor driving the cochlear implant market. According to the U.S. Census Bureau (2015), 8.5% of people across the globe i.e., 617 million were over age 65.

Reference: 180174
Price: $4,450.00
Tax included

General

Publisher:
Market Research Future
Geography Covered
Global
Publication Date
2017/12/16
Pages
114
Language
  • English
Format
License

Cochlear implants are used to treat the hearing problems in deaf patients. These implant has replaced the old hearing aid devices. Many manufacturers are involved in improving the quality and design of the cochlear implants. During the last few years, there has been a significant increase in the demand for cochlear implants. According to the research carried out by DeafandHoH.com LLC., in 2014, 360 million people worldwide were suffering from moderate to profound hearing loss. Additionally, according to the Centers for Disease Control and Prevention, by 2025, it is estimated that 900 million people across the globe are likely to suffer from hearing impairment of which around 90 million of these people may more likely from Europe.
Notably, rising geriatric population is the key factor driving the cochlear implant market. According to the U.S. Census Bureau (2015), 8.5% of people across the globe i.e., 617 million were over age 65.
Other push factors such as, increasing number of patients having hearing loss, acceptance of hearing implants by the patients with hearing disorders, and favorable reimbursement policies are also propelling the growth of the market. According to the National Institute on Deafness and Other Communication Disorders, in 2013, approximately 324,200 registered devices have been implanted worldwide.
However, the cost of impacts can be more than USD 100,000 which are not affordable to the middle-class population, thus, the high cost of the implants may hamper the growth of the market.

 

Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increase in number of patients suffering from hearing loss (Weightage 37%)
4.2.2 Rising geriatric population (weightage 28%)
4.2.3 Acceptance of hearing implants by the patients with hearing disorders (Weightage 22%)
4.2.4 Favourable reimbursement policies (Weightage 13%)
4.3 Restraints
4.3.1 High cost of the devices
4.4 Opportunity
4.5 Trends
5 Global Cochlear Implants Market, By Product
5.1 Introduction
5.2 Cochlear Implant System
5.3 Accessories & Upgrades
6 Global Cochlear Implants Market, By Type
6.1 Introduction
6.2 Unilaterals Implant
6.3 Bilateral Implant
7 Global Cochlear Implants Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
7.3 Ambulatory Surgical Centers
7.4 Research & Academic Institutes
8 Global Cochlear Implants Market, By Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 U.K.
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Republic of Korea
8.4.6 Rest of Asia Pacific
8.5 The Middle East & Africa
8.5.1 United Arab Emirates
8.5.2 Saudi Arabia
8.5.3 Oman
8.5.4 Kuwait
8.5.5 Qatar
8.5.6 Rest of Middle East & Africa
9 Company Landscape
9.1 Introduction
9.2 Company Share Analysis
9.3 Key Developments

10 Company Profiles
10.1 Advanced Bionics AG
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Products
10.1.4 Strategy
10.1.5 Key Developments
10.2 MED-EL
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Products
10.2.4 Strategy
10.2.5 Key Developments
10.3 Cochlear Ltd
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Products
10.3.4 Strategy
10.3.5 Key Developments
10.4 GAES MÉDICA
10.4.1 Company Overview
10.4.2 Financials
10.4.3 Products
10.4.4 Strategy
10.4.5 Key Developments
10.5 William Demant Holding Group
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Products
10.5.4 Strategy
10.5.5 Key Developments
10.6 Widex
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Products
10.6.4 Strategy
10.6.5 Key Developments
10.7 Microson S.A.
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Products
10.7.4 Strategy
10.7.5 Key Developments
11 Conclusion
11.1 Key Findings
11.1.1 CEO’s Viewpoint
11.1.2 Unmet Needs
11.1.3 Key Companies to Watch
12 Appendix
12.1 Discussion Blue Print
12.2 References

 

Scroll